AS Latvijas Juras medicinas centrs (RSE: LJM1R)
Latvia flag Latvia · Delayed Price · Currency is EUR
6.50
-0.30 (-4.41%)
At close: Dec 17, 2024

RSE: LJM1R Statistics

Total Valuation

AS Latvijas Juras medicinas centrs has a market cap or net worth of EUR 5.28 million. The enterprise value is 4.45 million.

Market Cap 5.28M
Enterprise Value 4.45M

Important Dates

The last earnings date was Wednesday, November 27, 2024.

Earnings Date Nov 27, 2024
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 279,920

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 0.86
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.71, with an EV/FCF ratio of 107.40.

EV / Earnings -5.86
EV / Sales 0.44
EV / EBITDA 10.71
EV / EBIT n/a
EV / FCF 107.40

Financial Position

The company has a current ratio of 0.89

Current Ratio 0.89
Quick Ratio 0.80
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -11.66% and return on invested capital (ROIC) is -1.97%.

Return on Equity (ROE) -11.66%
Return on Assets (ROA) -1.37%
Return on Capital (ROIC) -1.97%
Revenue Per Employee 27,856
Profits Per Employee -2,078
Employee Count 366
Asset Turnover 1.07
Inventory Turnover 60.81

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.67% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -34.67%
50-Day Moving Average 6.88
200-Day Moving Average 8.96
Relative Strength Index (RSI) 44.90
Average Volume (20 Days) 9

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, AS Latvijas Juras medicinas centrs had revenue of EUR 10.20 million and -760,420 in losses. Loss per share was -0.95.

Revenue 10.20M
Gross Profit 948,949
Operating Income -208,283
Pretax Income -759,531
Net Income -760,420
EBITDA 415,575
EBIT -208,283
Loss Per Share -0.95
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 827,126
Total Debt n/a
Net Cash 827,126
Net Cash Per Share n/a
Equity (Book Value) 6.15M
Book Value Per Share 7.69
Working Capital -169,200
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 430,754 and capital expenditures -389,295, giving a free cash flow of 41,459.

Operating Cash Flow 430,754
Capital Expenditures -389,295
Free Cash Flow 41,459
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 9.31%, with operating and profit margins of -2.04% and -7.46%.

Gross Margin 9.31%
Operating Margin -2.04%
Pretax Margin -7.45%
Profit Margin -7.46%
EBITDA Margin 4.08%
EBIT Margin -2.04%
FCF Margin 0.41%

Dividends & Yields

AS Latvijas Juras medicinas centrs does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -14.62%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AS Latvijas Juras medicinas centrs has an Altman Z-Score of 2.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.99
Piotroski F-Score n/a